SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Larsson Matilda)
 

Sökning: WFRF:(Larsson Matilda) > Endocardial border ...

Endocardial border delineation capability of a multimodal polymer-shelled contrast agent

Larsson, Malin K. (författare)
KTH Royal Institute of Technology, Stockholm, Sweden
Larsson, Matilda (författare)
KTH Royal Institute of Technology, Stockholm, Sweden and Karolinska Institutet, Solna, Sweden
Nowak, Greg (författare)
Karolinska Institutet, Stockholm, Sweden
visa fler...
Paradossi, Gaio (författare)
Università di Roma Tor Vergata, Rome, Italy
Brodin, Lars-Åke (författare)
KTH Royal Institute of Technology, Stockholm, Sweden and Karolinska Institutet, Solna, Sweden
Janerot Sjöberg, Birgitta (författare)
KTH Royal Institute of Technology, Stockholm, Sweden and Karolinska Institutet, Solna, Sweden
Caidahl, Kenneth (författare)
Karolinska Institutet, Solna, Sweden
Bjällmark, Anna (författare)
visa färre...
 (creator_code:org_t)
2014
2014
Engelska.
  • Konferensbidrag (övrigt vetenskapligt/konstnärligt)
Abstract Ämnesord
Stäng  
  • BackgroundA novel polymer-shelled contrast agent (CA) with high mechanical and chemical stability was recently developed [1]. In excess to its ultrasound properties, it also supports targeted and multimodal imaging [2-4]. Even though these new possibilities have the potential to lead to new methodologies and approaches for non-invasive diagnosis, it is important that the fundamental diagnostic features in contrast-enhanced ultrasound are preserved. The aim of this study was therefore to examine the clinical use of the polymer-shelled CA by analyzing the left ventricular endocardial border delineation capability in a porcine model. In addition, physiological effects due to CA injections were studied.MethodsThe endocardial border delineation capability was assessed in a comparative study, which included three doses (1.5 ml, 3 ml and 5 ml, [5x108 MBs/ml]) of the polymer-shelled CA and the commercially available CA SonoVue® (1.5 ml, [2-5x108 MBs/ml]). Ultrasound images of the left ventricle were evaluated manually by blinded observers (n=3) according to a 6-segment model, in which each segment was graded as 0=not visible, 1=barely visible or 2=well visible, as well as semi-automatically by a segmentation software. Furthermore, duration of clinically useful contrast enhancement and changes in physiological parameters were evaluated.ResultsFor the highest dose of the polymer-shelled CA, the obtained segment scores, time for clinically sufficient contrast enhancement and semi-automatic delineation capability were comparable to SonoVue®. Moreover, neither dose of the polymer-shelled CA did affect the physiological parameters.ConclusionThis study demonstrated that the polymer-shelled CA can be used in contrast-enhanced diagnostic imaging without influence on major physiological parameters.

Ämnesord

TEKNIK OCH TEKNOLOGIER  -- Medicinteknik -- Medicinsk bildbehandling (hsv//swe)
ENGINEERING AND TECHNOLOGY  -- Medical Engineering -- Medical Image Processing (hsv//eng)

Publikations- och innehållstyp

vet (ämneskategori)
kon (ämneskategori)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy